Prognostic value of circulating tumor DNA (ctDNA) for recurrence detection across solid tumors: A real-world meta-analysis.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Scott Kopetz, George Laliotis, Maen Abdelrahim, Midhun Malla, Richard D. Kim, Robert C. G. Martin, Arnab Basu, Aditya Bardia, Luke D. Jacobsen, Shruti Sharma, Michael Toboni, Gary Schwartz, Zeynep Eroglu, Samuel J. Klempner, Gregory P. Botta, Marla Lipsyc-Sharf, Adham A. Jurdi, Minetta C. Liu, Alexey Aleshin, Matthew D. Galsky
Institutions: The University of Texas MD Anderson Cancer Center, Houston Methodist, University of Alabama at Birmingham, Moffitt Cancer Center, University of Louisville, Mayo Clinic in Florida, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Baylor Scott & White Research Institute, Mass General Brigham, Moores Cancer Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162525476
Cites:
Cited by:
Related to:
